Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.010.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.55% | -40.82% | -26.31% | -38.48% | -100.51% |
| Total Depreciation and Amortization | 107.41% | 8.47% | 0.00% | 7.69% | -3.57% |
| Total Amortization of Deferred Charges | 14.71% | 18.56% | 14.74% | 16.48% | 17.24% |
| Total Other Non-Cash Items | 151.97% | 134.64% | 0.76% | 4.26% | -4.58% |
| Change in Net Operating Assets | -0.79% | -98.04% | -133.17% | -267.29% | 609.12% |
| Cash from Operations | -15.06% | -86.69% | -38.90% | -107.60% | -56.17% |
| Capital Expenditure | -650.00% | -1,186.36% | 50.00% | -57.14% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -338.13% | -84.57% | -639.43% | 4.91% | 224.34% |
| Cash from Investing | -338.31% | -86.02% | -639.79% | 4.87% | 224.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13,732.14% | 151,704.17% | 62,528.38% | -- | -99.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 67,295.71% | 151,704.17% | 66,005.41% | 112.08% | -99.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.75% | 110.64% | 1,004.10% | -182.59% | 644.81% |